OMass Therapeutics
Trending Articles
Related Content
Research & Development
Native mass spectrometry as a drug discovery engine
Using mass spectrometry to characterise and screen large intact protein targets, captured directly in their native state, is making waves as a differentiated approach to hit finding in drug discovery, explains Dr Jonathan T.S. Hopper, founder and VP of Platforms at OMass Therapeutics
Regulatory
OMass founder honoured with two prizes in chemistry
The 2022 Louis-Jeantet Prize for Medicine and the 2022 Benjamin Franklin Medal in Chemistry add to Professor Robinson’s list of achievements this year, having been awarded the 2022 European Chemistry Gold Medal from the European Chemical Society in August